PERSPECTA

News from every angle

Back to headlines

Moderna Gains as Arbutus/Genevant Settlement Removes Financial Risk

Moderna's stock gained after a settlement with Arbutus and Genevant removed a major financial risk for the company.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.